These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10944377)

  • 21. In vivo release kinetics of octreotide acetate from experimental polymeric microsphere formulations using oil/water and oil/oil processes.
    Murty SB; Wei Q; Thanoo BC; DeLuca PP
    AAPS PharmSciTech; 2004 Sep; 5(3):e49. PubMed ID: 15760082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design and development of a novel controlled release PLGA alginate-pectinate polyspheric drug delivery system.
    Sweet JL; Pillay V; Choonara YE
    Drug Deliv; 2007 Jul; 14(5):309-18. PubMed ID: 17613019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Population pharmacodynamic analysis of octreotide in acromegalic patients.
    Comets E; Mentré F; Grass P; Kawai R; Marbach P; Vonderscher J
    Clin Pharmacol Ther; 2003 Jan; 73(1):95-106. PubMed ID: 12545148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated temperature accelerated release testing of PLGA microspheres.
    Zolnik BS; Leary PE; Burgess DJ
    J Control Release; 2006 May; 112(3):293-300. PubMed ID: 16644055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo release of peptide-loaded PLGA microspheres assessed through deconvolution coupled with mechanistic approach.
    Tomic I; Mueller-Zsigmondy M; Vidis-Millward A; Cardot JM
    Eur J Pharm Biopharm; 2018 Apr; 125():21-27. PubMed ID: 29277580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. β-methasone-containing biodegradable poly(lactide-co-glycolide) acid microspheres for intraarticular injection: effect of formulation parameters on characteristics and in vitro release.
    Song X; Song SK; Zhao P; Wei LM; Jiao HS
    Pharm Dev Technol; 2013; 18(5):1220-9. PubMed ID: 22295954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Site-specific administration of antisense oligonucleotides using biodegradable polymer microspheres provides sustained delivery and improved subcellular biodistribution in the neostriatum of the rat brain.
    Khan A; Sommer W; Fuxe K; Akhtar S
    J Drug Target; 2000; 8(5):319-34. PubMed ID: 11328659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation of sustained release microparticles with improved initial release property.
    Jung GY; Na YE; Park MS; Park CS; Myung PK
    Arch Pharm Res; 2009 Mar; 32(3):359-65. PubMed ID: 19387579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Naltrexone-loaded poly[La-(Glc-Leu)] polymeric microspheres for the treatment of alcohol dependence: in vitro characterization and in vivo biocompatibility assessment.
    Pagar KP; Vavia PR
    Pharm Dev Technol; 2014 Jun; 19(4):385-94. PubMed ID: 23590187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclosporine-loaded microspheres for treatment of uveitis: in vitro characterization and in vivo pharmacokinetic study.
    He Y; Liu Y; Liu Y; Wang J; Zhang X; Lu W; Ma Z; Zhu X; Zhang Q
    Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3983-8. PubMed ID: 16936114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of mean diameter and polydispersity of PLG microspheres on drug release: experiment and theory.
    Berchane NS; Carson KH; Rice-Ficht AC; Andrews MJ
    Int J Pharm; 2007 Jun; 337(1-2):118-26. PubMed ID: 17289316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of additives on the release profile of nifedipine from poly(DL-lactide-co-glycolide) microspheres.
    Sansdrap P; Moës AJ
    J Microencapsul; 1998; 15(5):545-53. PubMed ID: 9743911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic and technical comparison of Sandostatin® LAR® and other formulations of long-acting octreotide.
    Petersen H; Bizec JC; Schuetz H; Delporte ML
    BMC Res Notes; 2011 Sep; 4():344. PubMed ID: 21906300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methadone implants for methadone maintenance treatment. In vitro and in vivo animal studies.
    Negrín CM; Delgado A; Llabrés M; Evora C
    J Control Release; 2004 Mar; 95(3):413-21. PubMed ID: 15023453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IVIVC of parenteral PLGA microspheres.
    Park K
    J Control Release; 2015 Nov; 218():116. PubMed ID: 26526216
    [No Abstract]   [Full Text] [Related]  

  • 36. In vitro evaluation of suspoemulsions for in situ-forming polymeric microspheres and controlled release of progesterone.
    Turino LN; Mariano RN; Mengatto LN; Luna JA
    J Microencapsul; 2015; 32(6):538-46. PubMed ID: 26218541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validation of a cage implant system for assessing in vivo performance of long-acting release microspheres.
    Doty AC; Hirota K; Olsen KF; Sakamoto N; Ackermann R; Feng MR; Wang Y; Choi S; Qu W; Schwendeman A; Schwendeman SP
    Biomaterials; 2016 Dec; 109():88-96. PubMed ID: 27693924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of spray-drying parameters on phase behavior, drug distribution, and in vitro release of injectable microspheres for sustained release.
    Meeus J; Lenaerts M; Scurr DJ; Amssoms K; Davies MC; Roberts CJ; Van Den Mooter G
    J Pharm Sci; 2015 Apr; 104(4):1451-60. PubMed ID: 25648704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of in vitro-in vivo correlation of parenteral naltrexone loaded polymeric microspheres.
    Andhariya JV; Shen J; Choi S; Wang Y; Zou Y; Burgess DJ
    J Control Release; 2017 Jun; 255():27-35. PubMed ID: 28385676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo.
    Mittal G; Sahana DK; Bhardwaj V; Ravi Kumar MN
    J Control Release; 2007 May; 119(1):77-85. PubMed ID: 17349712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.